CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Lanyon Oppositions against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025
High-Purity Peg Lipids And Uses ThereofMODERNATXJul 2, 2025
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEJun 17, 2025
Adjuvant Treatment Of Her2-Positive Breast CancerF HOFFMANN LA ROCHEJul 31, 2024
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 30, 2024
New UseNOVARTISJul 11, 2024

Top competitors of Lanyon Oppositions

List of top competitors of Lanyon Oppositions based on patent oppositions.